Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy

被引:7
|
作者
Karlsson, Kristin [1 ,2 ]
Lax, Ingmar [1 ,2 ]
Lindback, Elias [1 ,2 ]
Grozman, Vitali [3 ,4 ]
Lindberg, Karin [2 ,5 ]
Wersall, Peter [2 ,6 ]
Poludniowski, Gavin [2 ,7 ]
机构
[1] Karolinska Univ Hosp, Dept Med Radiat Phys & Nucl Med, Sect Radiotherapy Phys & Engn, Stockholm, Sweden
[2] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Radiol, Sect Thorac Radiol, Stockholm, Sweden
[4] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Canc, Sect Head Neck Lung & Skin Tumours, Stockholm, Sweden
[6] Karolinska Univ Hosp, Dept Canc, Sect Radiotherapy, Stockholm, Sweden
[7] Karolinska Univ Hosp, Dept Med Radiat Phys & Nucl Med, Stockholm, Sweden
来源
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS | 2021年 / 88卷
关键词
Stereotactic body radiation therapy; Delivered CTV dose; Geometrical uncertainties; Dose-shift; CALCULATION ALGORITHMS; RADIOTHERAPY SBRT; DOSIMETRIC IMPACT; CANCER; MARGINS; PROBABILITY; EFFICACY; ACCURACY; ERRORS; FRAME;
D O I
10.1016/j.ejmp.2021.06.015
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Dose-response relationships for local control of lung tumours treated with stereotactic body radiotherapy (SBRT) have proved ambiguous, however, these have been based on the prescribed or planned dose. Delivered dose to the target may be a better predictor for local control. In this study, the probability of the delivered minimum dose to the clinical target volume (CTV) in relation to the prescribed dose was estimated for a cohort of patients, considering geometrical uncertainties. Materials and methods: Delivered doses were retrospectively simulated for 50 patients treated with SBRT for lung tumours, comparing two image-guidance techniques: pre-treatment verification computed tomography (IG1) and online cone-beam computed tomography (IG2). The prescribed dose was typically to the 67% isodose line of the treatment plan. Simulations used in-house software that shifted the static planned dose according to a breathing motion and sampled setup/matching errors. Each treatment was repeatedly simulated, generating a multiplicity of dose-volume histograms (DVH). From these, tumour-specific and population-averaged statistics were derived. Results: For IG1, the probability that the minimum CTV dose (D98%) exceeded 100% of the prescribed dose was 90%. With IG2, this probability increased to 99%. Conclusions: Doses below the prescribed dose were delivered to a considerably larger part of the population prior to the introduction of online soft-tissue image-guidance. However, there is no clear evidence that this impacts local control, when compared to previous published data.
引用
收藏
页码:53 / 64
页数:12
相关论文
共 50 条
  • [21] Optimizing the Delivery of Intensity-Modulated Stereotactic Body Radiation Therapy to Lung Tumours Influenced by Respiratory Motion
    Gaede, S.
    Hamelin, N.
    Kline, M.
    Goosheh, S.
    Yartsev, S.
    Chen, J.
    MEDICAL PHYSICS, 2011, 38 (06)
  • [22] STEREOTACTIC BODY RADIATION THERAPY FOR PATIENTS WITH LUNG CANCER
    Bianchi, L. C.
    Beltramo, G.
    Brait, L.
    Bergantin, A.
    Locatelli, F.
    Fariselli, L.
    Gerosa, C.
    Mariani, P.
    Tabiadon, D.
    Locatelli, M. C.
    ANNALS OF ONCOLOGY, 2009, 20
  • [23] Investigation of Delivered Stereotactic Body Radiation Therapy Doses in Hepatocellular Carcinoma Patients Treated With Concurrent Sorafenib
    Chen, J.
    Bissonnette, J. P.
    Craig, T.
    Munoz, P.
    Dawson, L. A.
    Velec, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E195 - E195
  • [24] Prognostic Value of Anemia in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
    Nonaka, H.
    Onishi, H.
    Funayama, S.
    Watanabe, H.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S540 - S540
  • [25] Analysis of Local Failure of Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
    Liu, H.
    Cherian, S.
    Stephans, K.
    Videtic, G.
    Qi, P.
    Xia, P.
    Zhuang, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S737 - S737
  • [26] Evaluation of initial setup accuracy and intrafraction motion for spine stereotactic body radiation therapy using stereotactic body frames
    Han, Zhaohui
    Bondeson, John C.
    Lewis, John H.
    Mannarino, Edward G.
    Friesen, Scott A.
    Wagar, Matthew M.
    Balboni, Tracy A.
    Alexander, Brian M.
    Arvold, Nils D.
    Sher, David J.
    Hacker, Fred L.
    PRACTICAL RADIATION ONCOLOGY, 2016, 6 (01) : E17 - E24
  • [27] Spatial signature of dose patterns associated with acute radiation-induced lung damage in lung cancer patients treated with stereotactic body radiation therapy
    Palma, Giuseppe
    Monti, Serena
    Thor, Maria
    Rimner, Andreas
    Deasy, Joseph O.
    Cella, Laura
    PHYSICS IN MEDICINE AND BIOLOGY, 2019, 64 (15):
  • [28] Four-dimensional planning for motion synchronized dose delivery in lung stereotactic body radiation therapy
    Tachibana, Hidenobu
    Sawant, Amit
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 (03) : 467 - 472
  • [29] Accuracy of the dose-shift approximation in estimating the delivered dose in SBRT of lung tumors considering setup errors and breathing motions
    Karlsson, Kristin
    Lax, Ingmar
    Lindback, Elias
    Poludniowski, Gavin
    ACTA ONCOLOGICA, 2017, 56 (09) : 1189 - 1196
  • [30] Local Control and Toxicity in a Large Cohort of Central Lung Tumors Treated With Stereotactic Body Radiation Therapy
    Modh, Ankit
    Rimner, Andreas
    Williams, Eric
    Foster, Amanda
    Shah, Mihir
    Shi, Weiji
    Zhang, Zhigang
    Gelblum, Daphna Y.
    Rosenzweig, Kenneth E.
    Yorke, Ellen D.
    Jackson, Andrew
    Wu, Abraham J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (05): : 1168 - 1176